JP2015529454A5 - - Google Patents

Download PDF

Info

Publication number
JP2015529454A5
JP2015529454A5 JP2015524428A JP2015524428A JP2015529454A5 JP 2015529454 A5 JP2015529454 A5 JP 2015529454A5 JP 2015524428 A JP2015524428 A JP 2015524428A JP 2015524428 A JP2015524428 A JP 2015524428A JP 2015529454 A5 JP2015529454 A5 JP 2015529454A5
Authority
JP
Japan
Prior art keywords
nucleic acid
nme1
nme family
state
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015524428A
Other languages
English (en)
Japanese (ja)
Other versions
JP6546087B2 (ja
JP2015529454A (ja
Filing date
Publication date
Priority claimed from PCT/US2012/060684 external-priority patent/WO2013059373A2/en
Application filed filed Critical
Priority claimed from PCT/US2013/051899 external-priority patent/WO2014018679A2/en
Publication of JP2015529454A publication Critical patent/JP2015529454A/ja
Publication of JP2015529454A5 publication Critical patent/JP2015529454A5/ja
Application granted granted Critical
Publication of JP6546087B2 publication Critical patent/JP6546087B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015524428A 2012-07-24 2013-07-24 Nmeバリアント種の発現および抑制 Expired - Fee Related JP6546087B2 (ja)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US201261675292P 2012-07-24 2012-07-24
US61/675,292 2012-07-24
US201261677442P 2012-07-30 2012-07-30
US61/677,442 2012-07-30
US201261679021P 2012-08-02 2012-08-02
US61/679,021 2012-08-02
US201261683155P 2012-08-14 2012-08-14
US61/683,155 2012-08-14
US201261684654P 2012-08-17 2012-08-17
US61/684,654 2012-08-17
US201261693712P 2012-08-27 2012-08-27
US61/693,712 2012-08-27
PCT/US2012/060684 WO2013059373A2 (en) 2011-10-17 2012-10-17 Media for stem cell proliferation and induction
USPCT/US2012/060684 2012-10-17
PCT/US2013/051899 WO2014018679A2 (en) 2012-07-24 2013-07-24 Nme variant species expression and suppression

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019090368A Division JP2019141100A (ja) 2012-07-24 2019-05-13 Nmeバリアント種の発現および抑制

Publications (3)

Publication Number Publication Date
JP2015529454A JP2015529454A (ja) 2015-10-08
JP2015529454A5 true JP2015529454A5 (enExample) 2016-09-15
JP6546087B2 JP6546087B2 (ja) 2019-07-17

Family

ID=49997968

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015524428A Expired - Fee Related JP6546087B2 (ja) 2012-07-24 2013-07-24 Nmeバリアント種の発現および抑制
JP2019090368A Pending JP2019141100A (ja) 2012-07-24 2019-05-13 Nmeバリアント種の発現および抑制
JP2021132192A Active JP7386210B2 (ja) 2012-07-24 2021-08-16 Nmeバリアント種の発現および抑制

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019090368A Pending JP2019141100A (ja) 2012-07-24 2019-05-13 Nmeバリアント種の発現および抑制
JP2021132192A Active JP7386210B2 (ja) 2012-07-24 2021-08-16 Nmeバリアント種の発現および抑制

Country Status (9)

Country Link
US (2) US20150203823A1 (enExample)
EP (2) EP2877586A4 (enExample)
JP (3) JP6546087B2 (enExample)
CN (2) CN111849874A (enExample)
AU (2) AU2013295811A1 (enExample)
CA (1) CA2880010A1 (enExample)
IL (1) IL236901B (enExample)
SG (2) SG11201606118SA (enExample)
WO (1) WO2014018679A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4086338A1 (en) 2011-03-17 2022-11-09 Minerva Biotechnologies Corporation Method for making pluripotent stem cells
EP2768945B1 (en) 2011-10-17 2022-01-05 Minerva Biotechnologies Corporation Media for stem cell proliferation and induction
EP4233536B1 (en) * 2013-08-12 2025-12-31 Minerva Biotechnologies Corporation TUMOR GROWTH STIMULATION METHOD
EP4050103A1 (en) * 2014-04-07 2022-08-31 Minerva Biotechnologies Corporation Anti-nme antibody
EP3256494A4 (en) 2015-02-10 2018-12-05 Minerva Biotechnologies Corporation Humanized anti-muc1* antibodies
CN109081863A (zh) * 2018-08-01 2018-12-25 西北民族大学 抗癌活性物质放线菌素fgr的分离鉴定方法
EP3920693A4 (en) 2019-02-04 2022-10-05 Minerva Biotechnologies Corporation ANTI-NME ANTIBODIES AND METHODS OF TREATMENT OF CANCER OR CANCER METASTASIS
JP2023530039A (ja) 2020-06-08 2023-07-12 ミネルバ バイオテクノロジーズ コーポレーション 抗nme抗体および癌または癌転移の治療方法
CA3183682A1 (en) 2020-06-26 2021-12-30 Minerva Biotechnologies Corporation Anti-nme antibody and method of treating cancer or cancer metastasis
CA3248038A1 (en) 2022-04-12 2023-10-19 Minerva Biotechnologies Corporation ANTI-MUC1* VARIABLE ANTIBODIES AND RELATED USES
CN122128303A (zh) * 2026-02-14 2026-06-02 中国人民解放军总医院第三医学中心 靶向性沉默C15ORF48基因的shRNA、重组质粒和慢病毒载体和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1425016B1 (en) * 2001-09-05 2010-06-02 Minerva Biotechnologies Corporation Compositions and methods of treatment of cancer
EP1375661A1 (en) * 2002-06-17 2004-01-02 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam The role of the N-myc - nm23H1/nm23H2 - cdc42 pathway in proliferation, differentiation and treatment of cancer
CN101273060A (zh) * 2005-06-24 2008-09-24 美国政府(由卫生和人类服务部、国立卫生研究院的部长所代表) 通过靶向肿瘤坏死因子受体的前配体装配域(plad)来缓解炎性关节炎
JP2008099662A (ja) * 2006-09-22 2008-05-01 Institute Of Physical & Chemical Research 幹細胞の培養方法
WO2008067065A2 (en) * 2006-10-19 2008-06-05 Shiv Srivastava Methods, kits, and systems for diagnosing and prognosing prostate cancer using secreted biomarkers
US20090075926A1 (en) * 2006-12-06 2009-03-19 Bamdad Cynthia C Method for identifying and manipulating cells
WO2009012173A2 (en) 2007-07-13 2009-01-22 Dharmacon, Inc. Enhanced biotherapeutic production using inhibitory rna
KR20160017117A (ko) * 2008-10-09 2016-02-15 미네르바 바이오테크놀로지 코포레이션 세포내에서 다능성을 유도하기 위한 방법
MX2011013385A (es) * 2009-06-11 2012-05-29 Minerva Biotechnologies Corp Metodos para cultivar celulas madre y celulas progenitoras.
EP3228629A1 (en) * 2010-06-16 2017-10-11 Minerva Biotechnologies Corporation Reprogramming cancer cells
WO2014012115A2 (en) * 2012-07-13 2014-01-16 Minerva Biotechnologies Corporation Method for inducing cells to less mature state

Similar Documents

Publication Publication Date Title
Silva et al. Long noncoding RNAs: a missing link in osteoporosis
Silber et al. microRNAs in gliomas: small regulators of a big problem
AU2011311344B2 (en) Short RNA molecules
CN106978415B (zh) 转运rna片段及其应用
Ujigo et al. Administration of microRNA-210 promotes spinal cord regeneration in mice
Gagan et al. MicroRNAs regulate and provide robustness to the myogenic transcriptional network
Plowright et al. Heart regeneration: opportunities and challenges for drug discovery with novel chemical and therapeutic methods or agents
Kim et al. Recent advances in gene therapy for cardiac tissue regeneration
Bei et al. SR proteins in cancer: function, regulation, and small inhibitor
Lou et al. Current status of nucleic acid therapy and its new progress in cancer treatment
Ottens et al. Physiological and pathophysiological role of nonsense-mediated mRNA decay
CN105492598A (zh) 与细胞的抗衰老相关的生物分子群
EP2794882A1 (en) microRNAs FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION
JP2019509297A (ja) ヒト間葉系幹細胞(hMSC)からギャップジャンクションを介するオリゴ送達に基づく癌治療
Choong et al. The roles of non-coding RNAs in cardiac regenerative medicine
Dong et al. Non‐coding RNAs in cardiomyocyte proliferation and cardiac regeneration: Dissecting their therapeutic values
JP7718819B2 (ja) 成体幹細胞の拡大と誘導のインビトロでの誘発
JPWO2011111824A1 (ja) マイクロrnaを用いた心筋細胞の増殖方法
Hudson et al. The non-coding road towards cardiac regeneration
CN112843082B (zh) Dna四面体在制备治疗糖尿病的药物中的用途
CN104830863A (zh) 一种抑制FABP4基因表达的siRNA及其应用
CN102533755A (zh) 人miR-328反义核酸及其应用
Najmuddin et al. The linkage between microRNA and cancer and its delivery as cancer therapy: a mini-review
CN103405784B (zh) c-Fos基因在制备抗癌药物中的应用
CN105779576B (zh) 人tnfrsf12a基因的用途及其相关药物